English 
Chinese
SmartDose® Gen. II 10mL Drug Delivery Platform
Adaptive technology for large dose volumes
Advances in therapeutic proteins have helped to create new and more targeted drug products for a variety of issues. However, higher viscosities may not allow for conventional delivery due to the need for longer injection times to reduce patient discomfort. The SmartDose® Generation II (Gen. II) drug delivery platform leverages the success of our Gen. I device with proven engineering and industrialization on a larger scale. With a dose volume of up to 10mL, the SmartDose Gen. II device can adapt to a variety of drug delivery needs.
PRECISE. RELIABLE. ADAPTIVE.
Patient-Centric Wearable Injector
- User loaded subcutaneous self-administration
- Ability to deliver high volume and high viscosity drug products Integrated connectivity
- Easy to use, intuitive design to create a better user-experience
- Making treatment more patient-centric with home administration
- Visual, tactile and audible feedback to boost user confidence
- Onboarding and training solutions
Flexible technology
- Formulation volumes up to 10mL
- Formulation viscosities up to 100cP
- Pre-programmable delivery times from minutes to hours
- Pre-programmable delivery profiles to accommodate specific therapeutic needs
- Continuous or pulsatile delivery modes
- Fill-finish offerings to simplify the path to market
Technical specifications
Downloadable Resources
SmartDose® Drug Delivery Platform Gen. I Information Sheet
SmartDose Drug Delivery Platform Gen. II Information Sheet
SmartDose Drug Delivery Platform Gen. III Information Sheet
SmartDose Drug Delivery Platform Traction Timeline
West's Fill Finish Capabilities
West & Swissfillon Partnership Information Sheet
Whitepaper on Integrated Digital Ecosystem
SmartDose® is a registered trademark of West Pharma. Services IL, Ltd., a subsidiary of West Pharmaceutical Services, Inc.
Flurotec® is a registered trademark of Daikyo Seiko, Ltd.
West markets SmartDose as a multi-component system only. Final assembly of the prefilled component is completed by the pharmaceutical company.
SelfDose™ is a trademark of West Pharmaceutical Services, Inc.
Simplify the Journey™ with Integrated Solutions for any molecule, at every stage.
From the Blog
February 06, 2019
West and Swissfillon to Partner on an Integrated Solution for Clinical Filling of SmartDose® Drug Delivery Platform
Altering Patient Treatment: How SC Delivery Can Help Patients Manage Chronic Conditions, p. 34